In previous studies, Sesn2 has been suggested to regulate the MAPK, AKT, AMPKα, and oxidative stress-associated signaling pathways, all of which have been implicated in the regulation of pathological cardiac hypertrophy. This evidence concerns the gene SESN2 and cardiac hypertrophy.